Zehri 2010.
Methods |
|
|
Participants |
|
|
Interventions | Treatment group
Control group
Both groups received 50 mg diclofenac twice daily for a maximum of 10 days and were allowed to drink 2 L of fluids daily. |
|
Outcomes |
|
|
Funding sources | None stated. | |
Declarations of interest | None stated. | |
Notes | Weekly follow‐up with KUB or US. Sample size was calculated. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Quote: “Randomization was done by assigning consecutive patients to alternate groups." Comment: This method of random sequence generation was considered to have high risk of bias. |
Allocation concealment (selection bias) | High risk | No quotes available. Comment: The type of allocation concealment used in this study was considered to have high risk of bias. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Quote: "open‐label." No blinding performed. Comment: Risk of performance bias was considered to be high. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No quotes available. No blinding of outcome assessments described. Comment: Owing to insufficient information, risk of detection bias was considered to be unclear. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No quotes available. Comment: one exclusion; therefore risk of attrition bias was considered to be low. |
Selective reporting (reporting bias) | Low risk | No quotes available. Expected outcomes were reported according to objectives. Comment: Risk of reporting bias was therefore considered to be low. |
Other bias | Low risk | No quotes available. Study appears to be free of other sources of bias. Comment: No other sources of bias could be found; therefore risk of other bias was considered to be low. |